RECURRENT PLEURAL MALIGNANT MESOTHELIOMA
Clinical trials for RECURRENT PLEURAL MALIGNANT MESOTHELIOMA explained in plain language.
Never miss a new study
Get alerted when new RECURRENT PLEURAL MALIGNANT MESOTHELIOMA trials appear
Sign up with your email to follow new studies for RECURRENT PLEURAL MALIGNANT MESOTHELIOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail offers hope for rare tumor patients
Disease control OngoingThis study tests whether combining two immunotherapy drugs, atezolizumab and bevacizumab, can shrink or control rare solid tumors that are hard to treat. About 133 adults with cancers like rare appendix, anal, cervical, penile, vulvar, neuroendocrine, Merkel cell, nasopharyngeal,…
Matched conditions: RECURRENT PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 26, 2026 09:23 UTC
-
Experimental combo aims to outsmart resistant cancers
Disease control OngoingThis study tests whether adding the experimental drug TRC102 to standard chemotherapy (cisplatin and pemetrexed) can shrink tumors or slow cancer growth in people with advanced solid tumors or mesothelioma that have not responded to prior treatments. About 30 adults will take par…
Matched conditions: RECURRENT PLEURAL MALIGNANT MESOTHELIOMA
Phase: PHASE1, PHASE2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 26, 2026 08:57 UTC